Ivemend ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

ivemend

merck sharp & dohme b.v. - fosaprepitant - vomiting; cancer - Противорвотные i antinauseants, - prevenciju mučnine i povraćanja kod visoko i umjereno emetogenic raka kemoterapija kod odraslih i pedijatrijski pacijenti u dobi od 6 mjeseci i stariji. ivemend 150 mg se daje kao dio kombinirane terapije.

Clexane 30 000 IU (300 mg)/3 ml otopina za injekciju ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

clexane 30 000 iu (300 mg)/3 ml otopina za injekciju

sanofi-aventis croatia d.o.o., heinzelova 70, zagreb - enoxaparinum natricum - otopina za injekciju - 30 000 iu (300 mg)/3 ml - urbroj: jedna bočica sadrži 30 000 iu anti xa aktivnosti enoksaparinnatrija (što odgovara 300 mg) + 45 mg benzilnog alkohola u 3,0 ml vode za injekcije

Hemlibra ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

hemlibra

roche registration limited - emicizumab - hemofilija a - antihemorrhagics - hemlibra is indicated for routine prophylaxis of bleeding episodes in patients with haemophilia a (congenital factor viii deficiency):with factor viii inhibitorswithout factor viii inhibitors who have:severe disease (fviii < 1%)moderate disease (fviii ≥ 1% and ≤ 5%) with severe bleeding phenotype. hemlibra mogu se koristiti u svim dobnim skupinama.

Ofev ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

ofev

boehringer ingelheim international gmbh - nintedanib - idiopatska plućna fibroza - antineoplastična sredstva - ofev je indiciran kod odraslih osoba za liječenje idiopatske plućne fibroze (ipf).